Stereotactic ablative radiotherapy as single treatment for early stage non-small cell lung cancer: A single institution analysis.

Although high survival rates can be achieved in ES-NSCLC patients treated with SABR, using SABR on its own may not be enough. Prolonged surveillance and adjuvant therapy is therefore needed.